Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zymeworks Bc Inc. (ZYME) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zymeworks Bc Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1403752.
Total stock buying since 2018: $439,324.
Total stock sales since 2018: $22,740,286.
Total stock option exercises since 2018: $1,925,333.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 5,000 | $71,375 | 5,454 | $40,540 | 13,488 | $0 |
| 2021 | 0 | $0 | 67,877 | $2,427,568 | 84,308 | $419,898 |
| 2020 | 8,075 | $367,949 | 94,350 | $4,694,769 | 93,920 | $1,043,427 |
| 2019 | 0 | $0 | 262,108 | $4,223,891 | 43,384 | $462,008 |
| 2018 | 0 | $0 | 808,438 | $11,353,518 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-11 | 0 | $0 | 2,475 | $20,045 | 5,885 | $0 |
| 2022-03 | 0 | $0 | 2,979 | $20,495 | 7,603 | $0 |
| 2022-01 | 5,000 | $71,375 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 4,900 | $73,500 |
| 2021-07 | 0 | $0 | 57,660 | $2,077,305 | 57,660 | $246,419 |
| 2021-04 | 0 | $0 | 950 | $26,533 | 2,266 | $0 |
| 2021-03 | 0 | $0 | 9,267 | $323,730 | 17,399 | $28,658 |
| 2021-02 | 0 | $0 | 0 | $0 | 2,083 | $71,321 |
| 2020-12 | 0 | $0 | 50,850 | $2,758,147 | 50,000 | $394,073 |
| 2020-11 | 0 | $0 | 3,500 | $136,622 | 2,920 | $99,980 |
| 2020-09 | 0 | $0 | 40,000 | $1,800,000 | 40,000 | $545,520 |
| 2020-04 | 575 | $19,199 | 0 | $0 | 1,000 | $3,854 |
| 2020-01 | 7,500 | $348,750 | 0 | $0 | 0 | $0 |
| 2019-12 | 0 | $0 | 0 | $0 | 27,500 | $412,500 |
| 2019-05 | 0 | $0 | 9,108 | $175,172 | 15,884 | $49,508 |
| 2019-03 | 0 | $0 | 3,000 | $48,719 | 0 | $0 |
| 2019-01 | 0 | $0 | 250,000 | $4,000,000 | 0 | $0 |
| 2018-11 | 0 | $0 | 700,000 | $9,800,000 | 0 | $0 |
| 2018-09 | 0 | $0 | 71,507 | $1,045,760 | 0 | $0 |
| 2018-08 | 0 | $0 | 36,931 | $507,758 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-10 | Josephson Neil (Chief Medical Officer) | Sale | 2,475 | 8.10 | 20,045 |
| 2022-11-10 | Josephson Neil (Chief Medical Officer) | Option Ex | 5,885 | .00 | 0 |
| 2022-03-10 | Josephson Neil (Chief Medical Officer) | Option Ex | 2,395 | .00 | 0 |
| 2022-03-10 | Klompas Neil A (Chief Operating Officer) | Sale | 2,979 | 6.88 | 20,495 |
| 2022-03-10 | Klompas Neil A (Chief Operating Officer) | Option Ex | 5,208 | .00 | 0 |
| 2022-01-07 | Josephson Neil (Chief Medical Officer) | Buy | 5,000 | 14.28 | 71,375 |
| 2021-08-31 | Polverino Anthony J. (Chief Scientific Officer) | Option Ex | 4,900 | 15.00 | 73,500 |
| 2021-07-16 | Tehrani Ali (Chief Executive Officer) | Sale | 41,191 | 36.00 | 1,482,876 |
| 2021-07-16 | Tehrani Ali (Chief Executive Officer) | Option Ex | 41,191 | 4.26 | 175,638 |
| 2021-07-15 | Tehrani Ali (Chief Executive Officer) | Sale | 3,800 | 36.00 | 136,800 |
| 2021-07-15 | Tehrani Ali (Chief Executive Officer) | Option Ex | 3,800 | 4.27 | 16,229 |
| 2021-07-12 | Tehrani Ali (Chief Executive Officer) | Sale | 12,669 | 36.12 | 457,629 |
| 2021-07-12 | Tehrani Ali (Chief Executive Officer) | Option Ex | 12,669 | 4.31 | 54,552 |
| 2021-04-13 | Priour James (Chief Commercial Officer) | Sale | 950 | 27.93 | 26,533 |
| 2021-04-13 | Priour James (Chief Commercial Officer) | Option Ex | 2,266 | .00 | 0 |
| 2021-03-15 | O'driscoll Kathryn (Chief People Officer) | Sale | 786 | 34.72 | 27,289 |
| 2021-03-15 | O'driscoll Kathryn (Chief People Officer) | Option Ex | 837 | 34.24 | 28,658 |
| 2021-03-10 | O'driscoll Kathryn (Chief People Officer) | Sale | 568 | 34.95 | 19,853 |
| 2021-03-10 | O'driscoll Kathryn (Chief People Officer) | Option Ex | 1,354 | .00 | 0 |
| 2021-03-10 | Klompas Neil A (Chief Financial Officer) | Sale | 1,425 | 34.95 | 49,809 |
| 2021-03-10 | Klompas Neil A (Chief Financial Officer) | Option Ex | 2,500 | .00 | 0 |
| 2021-03-10 | Tehrani Ali (Chief Executive Officer) | Sale | 4,392 | 34.95 | 153,517 |
| 2021-03-10 | Tehrani Ali (Chief Executive Officer) | Option Ex | 7,708 | .00 | 0 |
| 2021-03-10 | Polverino Anthony J. (Chief Scientific Officer) | Sale | 1,048 | 34.95 | 36,631 |
| 2021-03-10 | Polverino Anthony J. (Chief Scientific Officer) | Option Ex | 2,500 | .00 | 0 |
| 2021-03-10 | Hausman Diana (Chief Medical Officer) | Sale | 1,048 | 34.95 | 36,631 |
| 2021-03-10 | Hausman Diana (Chief Medical Officer) | Option Ex | 2,500 | .00 | 0 |
| 2021-02-12 | O'driscoll Kathryn (Chief People Officer) | Option Ex | 2,083 | 34.24 | 71,321 |
| 2020-12-09 | Klompas Neil A (Chief Financial Officer) | Sale | 25,000 | 53.24 | 1,331,125 |
| 2020-12-09 | Klompas Neil A (Chief Financial Officer) | Option Ex | 25,000 | 4.93 | 123,325 |
| 2020-12-07 | Tehrani Ali (Chief Executive Officer) | Sale | 850 | 56.16 | 47,736 |
| 2020-12-04 | Hausman Diana (Chief Medical Officer) | Sale | 6,032 | 55.12 | 332,477 |
| 2020-12-04 | Hausman Diana (Chief Medical Officer) | Option Ex | 6,032 | 10.83 | 65,326 |
| 2020-12-02 | Hausman Diana (Chief Medical Officer) | Sale | 701 | 55.01 | 38,562 |
| 2020-12-02 | Hausman Diana (Chief Medical Officer) | Option Ex | 701 | 10.83 | 7,591 |
| 2020-12-01 | Hausman Diana (Chief Medical Officer) | Sale | 18,267 | 55.20 | 1,008,247 |
| 2020-12-01 | Hausman Diana (Chief Medical Officer) | Option Ex | 18,267 | 10.83 | 197,831 |
| 2020-11-18 | O'driscoll Kathryn (Chief People Officer) | Option Ex | 2,920 | 34.24 | 99,980 |
| 2020-11-02 | Tehrani Ali (Chief Executive Officer) | Sale | 3,500 | 39.03 | 136,622 |
| 2020-09-14 | Hausman Diana (Chief Medical Officer) | Sale | 40,000 | 45.00 | 1,800,000 |
| 2020-09-14 | Hausman Diana (Chief Medical Officer) | Option Ex | 40,000 | 13.64 | 545,520 |
| 2020-04-13 | Tehrani Ali (Chief Executive Officer) | Option Ex | 1,000 | 3.85 | 3,854 |
| 2020-04-03 | Tehrani Ali (Chief Executive Officer) | Buy | 575 | 33.39 | 19,199 |
| 2020-01-27 | Cox Troy (Director) | Buy | 7,500 | 46.50 | 348,750 |
| 2019-12-12 | Polverino Anthony J. (Chief Scientific Officer) | Option Ex | 27,500 | 15.00 | 412,500 |
| 2019-05-06 | Poon David Kai Yuen (See Remarks) | Sale | 800 | 19.20 | 15,360 |
| 2019-05-06 | Poon David Kai Yuen (See Remarks) | Option Ex | 800 | 3.53 | 2,824 |
| 2019-05-06 | Klompas Neil A (Chief Financial Officer) | Sale | 8,308 | 19.24 | 159,812 |
| 2019-05-06 | Klompas Neil A (Chief Financial Officer) | Option Ex | 15,084 | 3.10 | 46,684 |
| 2019-03-29 | Tehrani Ali (Chief Executive Officer) | Sale | 3,000 | 16.24 | 48,719 |
| 2019-01-31 | Lilly Eli & Co | Sale | 250,000 | 16.00 | 4,000,000 |
| 2018-11-06 | Lilly Eli & Co | Sale | 700,000 | 14.00 | 9,800,000 |
| 2018-09-24 | Lilly Eli & Co | Sale | 2,027 | 16.36 | 33,161 |
| 2018-09-18 | Lilly Eli & Co | Sale | 6,870 | 14.56 | 100,027 |
| 2018-09-17 | Lilly Eli & Co | Sale | 6,865 | 14.58 | 100,091 |
| 2018-09-14 | Lilly Eli & Co | Sale | 9,009 | 14.58 | 131,351 |
| 2018-09-13 | Lilly Eli & Co | Sale | 20,900 | 14.32 | 299,288 |
| 2018-09-12 | Lilly Eli & Co | Sale | 10,059 | 14.83 | 149,174 |
| 2018-09-11 | Lilly Eli & Co | Sale | 11,277 | 14.87 | 167,688 |
| 2018-09-10 | Lilly Eli & Co | Sale | 4,500 | 14.44 | 64,980 |
| 2018-08-31 | Lilly Eli & Co | Sale | 700 | 14.26 | 9,982 |
| 2018-08-30 | Lilly Eli & Co | Sale | 3,440 | 14.35 | 49,364 |
| 2018-08-29 | Lilly Eli & Co | Sale | 2,312 | 14.26 | 32,969 |
| 2018-08-14 | Lilly Eli & Co | Sale | 3,000 | 14.28 | 42,840 |
| 2018-08-13 | Lilly Eli & Co | Sale | 4,531 | 14.33 | 64,929 |
| 2018-08-10 | Lilly Eli & Co | Sale | 1,898 | 14.28 | 27,103 |
| 2018-08-03 | Lilly Eli & Co | Sale | 1,650 | 13.55 | 22,357 |
| 2018-08-02 | Lilly Eli & Co | Sale | 19,400 | 13.31 | 258,214 |
Insider trading activities including stock purchases, stock sales, and option exercises of ZYME listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zymeworks Bc Inc. (symbol ZYME, CIK number 1403752) see the Securities and Exchange Commission (SEC) website.